AJP - Endo Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (January 6, 2009). doi:10.1152/ajpendo.90517.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/E503    most recent
90517.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burger, N. Z
Right arrow Articles by Gokina, N. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burger, N. Z
Right arrow Articles by Gokina, N. I
Submitted on June 18, 2008
Revised on December 12, 2008
Accepted on January 2, 2009

Estrogen Replacement Enhances EDHF-Mediated Vasodilation of Mesenteric and Uterine Resistance Arteries: the Role of Endothelial Cell Ca2+

Natalie Z Burger1, Olga Y Kuzina1, George Osol1, and Natalia I Gokina1*

1 University of Vermont College of Medicine

* To whom correspondence should be addressed. E-mail: Natalia.Gokina{at}uvm.edu.

Endothelial-derived hyperpolarizing factor (EDHF) plays an important role in the regulation of vascular microcirculatory tone. This study explores the role of estrogen in controlling EDHF-mediated vasodilation of resistance uterine arteries of the rat and also analyzes the contribution of endothelial cell Ca2+ signaling to this process. A parallel study was also performed using mesenteric arteries to provide comparison with a non-reproductive vasculature. Mature female rats underwent ovariectomy, with one-half receiving 17ß-estradiol replacement (OVX+E) and the other half serving as estrogen-deficient controls (OVX). Uterine or mesenteric resistance arteries were harvested, cannulated, and pressurized. NO and prostacyclin production were inhibited with 200 µM LNNA and 10 µM indomethacin, respectively. ACh effectively dilated the arteries pre-constricted with phenylephrine, but failed to induce dilatation of vessels pre-constricted with high K+ solution. ACh EC50 values were decreased by estrogen replacement by 5- and 2-fold in uterine and mesenteric arteries, respectively. As evidenced from fura 2-based measurements of endothelial cell cytoplasmic Ca2+ (EC [Ca2+]i), estrogen replacement was associated with increased basal and ACh-stimulated EC [Ca2+]i rise in uterine, but not in mesenteric vessels. These data demonstrate that EDHF contributes to endothelium-dependent vasodilation of resistance uterine and mesenteric arteries and that estrogen controls EDHF-related mechanism(s) more efficiently in reproductive vs. non-reproductive vessels. Enhanced endothelial Ca2+ signaling may be an important underlying mechanism in estrogenic modulation of EDHF-mediated vasodilation in small resistance uterine arteries.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.